ESR1 and breast cancer: To do so, they collected CD45 positive cells from treatment-naïve breast cancer patients including estrogen receptor (ER+) and progesterone receptor (PR+) positive, human epidermal growth factor receptor 2 amplified (HER2+) and triple negative (TNBC) tumors.